ArticleAlimentary pharmacology & therapeutics2023

Letter: higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbidities.

Jannis Kountouras et al.PubMed ↗Publisher ↗

No numbers read from the abstract.